Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Collins

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|June 1, 1995
Serum granulocyte colony-stimulating factor (G-CSF) levels after allogeneic T cell-depleted marrow transplantationV Papadakis, T Diaz-Barrientos, G Heller, et al.
Blood|September 1, 1986
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host diseaseN A Kernan, N H Collins, L Juliano, et al.
Bone Marrow Transplantation|April 1, 1995
Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?S Mackinnon, E B Papadopoulos, M H Carabasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4C A Keever, K Pekle, M V Gazzola, et al.
Immunogenetics|January 1, 1984
Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypesS Y Yang, Y Morishima, N H Collins, et al.
Transplantation|June 1, 1989
T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beadsJ N Frame, N H Collins, T Cartagena, et al.
Clinical Immunology and Immunopathology|September 1, 1988
Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiencyC A Keever, N Flomenberg, J Brochstein, et al.
Human Immunology|September 1, 1990
Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency diseaseC A Keever, N Flomenberg, M V Gazzola, et al.
Annals of the New York Academy of Sciences|January 1, 1987
The role of residual host immunity in graft failures following T-cell-depleted marrow transplants for leukemiaC Bordignon, N A Kernan, C A Keever, et al.
Progress in Clinical and Biological Research|January 1, 1992
New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical resultsN H Collins, M H Carabasi, S Bleau, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|June 1, 1995
Serum granulocyte colony-stimulating factor (G-CSF) levels after allogeneic T cell-depleted marrow transplantationV Papadakis, T Diaz-Barrientos, G Heller, et al.
Blood|September 1, 1986
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host diseaseN A Kernan, N H Collins, L Juliano, et al.
Bone Marrow Transplantation|April 1, 1995
Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?S Mackinnon, E B Papadopoulos, M H Carabasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4C A Keever, K Pekle, M V Gazzola, et al.
Immunogenetics|January 1, 1984
Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypesS Y Yang, Y Morishima, N H Collins, et al.
Transplantation|June 1, 1989
T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beadsJ N Frame, N H Collins, T Cartagena, et al.
Clinical Immunology and Immunopathology|September 1, 1988
Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiencyC A Keever, N Flomenberg, J Brochstein, et al.
Human Immunology|September 1, 1990
Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency diseaseC A Keever, N Flomenberg, M V Gazzola, et al.
Annals of the New York Academy of Sciences|January 1, 1987
The role of residual host immunity in graft failures following T-cell-depleted marrow transplants for leukemiaC Bordignon, N A Kernan, C A Keever, et al.
Progress in Clinical and Biological Research|January 1, 1992
New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical resultsN H Collins, M H Carabasi, S Bleau, et al.
Pageof 4